Amberen

$40 million judgment (partially suspended)/ Prohibited from making any weight loss or menopause-related unless substantiated by competent and reliable scientific evidence that consists of human clinical testing that is sufficient in quality and quantity, based on standards generally accepted by experts in the relevant disease, condition, or function to which the representation relates, when considered in light of the entire body of relevant and reliable evidence / Such testing shall be randomized, double-blind, and placebo-controlled and conducted by qualified persons / Other health-related claims must be supported by competent and reliable scientific evidence that has been conducted and evaluated in an objective manner by experts in the relevant disease, condition, or function to which the representation relates, and must be randomized, double-blind, and placebo-controlled when such experts would generally require such testing / All underlying data must be preserved and available for inspection and production to the FTC / Prohibited from misrepresenting any test, study, or material facts or connections regarding endorsements